Foundation Medicine (NASDAQ: FMI) (Acquired)

A molecular diagnostics test that examines somatic alterations in cancer-related genes by applying massively parallel sequencing to routine clinical s...

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Foundation Medicine (NASDAQ: FMI) (Acquired) plus 5119 other startups.

Start Free 7 Day Trial Now

Learn More About Foundation Medicine (NASDAQ: FMI) (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Our Clients